Insider trades

Richard A. Paulson, CEO of Karyopharm Therapeutics KPTI, has filed 0 purchases and 36 sales on the open market. Over the past 12 months that comes to a net sale of $137.2K. The latest trade was on 05/14.

Richard A. Paulson

President and CEO
First filing
23/01/05
Trades
51 trades
Buys / sales
0 / 36
12-month net buying
−$137.2K
Last trade
05/14

Trading activity

Transactions

Trade type
Open-market sale05/1405/152,203 sh$9.50$20,928.5−0.8%
Open-market sale03/0203/0312,361 sh$9.41$116,317.01−4.4%
Open-market sale25/09/1525/09/161,257 sh$6.43$8,082.51−1.5%
Open-market sale25/05/0625/05/07236 sh$7.12$1,680.32−0.3%
Open-market sale25/04/0425/04/07245 sh$3.74$916.3−0.3%
Open-market sale25/03/0425/03/0611,694 sh$6.29$73,555.26−12.4%
Open-market sale25/02/0425/02/054,099 sh$0.65$2,664.35−0.4%
Open-market sale25/01/0625/01/074,055 sh$0.78$3,162.9−0.4%
Open-market sale24/12/0424/12/053,620 sh$0.81$2,932.2−0.3%
Open-market sale24/11/0524/11/063,675 sh$0.91$3,344.25−0.3%
Open-market sale24/10/0424/10/073,607 sh$0.88$3,174.16−0.3%
Open-market sale24/09/0424/09/053,667 sh$0.72$2,640.24−0.3%
Open-market sale24/08/0624/08/083,608 sh$0.93$3,355.44−0.3%
Open-market sale24/07/0524/07/093,616 sh$0.85$3,073.6−0.3%
Open-market sale24/06/0424/06/063,592 sh$0.99$3,556.08−0.3%
Open-market sale24/05/0624/05/073,576 sh$1.13$4,040.88−0.3%
Open-market sale24/04/0424/04/053,563 sh$1.29$4,596.27−0.3%
Open-market sale24/03/0524/03/063,573 sh$1.30$4,644.9−0.3%
KPTI
Open-market sale24/02/29–24/03/0124/03/0499,844 sh2 trades$1.18avg.$117,398.7−7.9%
Open-market sale24/02/0624/02/084,012 sh$1.59$6,379.08−0.5%